Portfolio value
$171.31B
Holdings count
4
4 positions reportedAccession #
0002081668-26-000003
Form 13F-HR4 positions sorted by value
Issuer | CUSIP | Valuev | Weight | Shares/Prin. | Discretion | Voting (Sole/Shared/None) |
|---|---|---|---|---|---|---|
CYTOKINETICS, INCCOM | 23282W605 | $62.29B | 36.36% | 980,392shares | DFND | 980,392 / 0 / 0 |
ZENAS BIOPHARMA, INC.COM | 055477103 | $45.86B | 26.77% | 1,263,150shares | DFND | 1,263,150 / 0 / 0 |
BIOHAVEN LTDCOM | G1110E107 | $33.15B | 19.35% | 2,936,507shares | DFND | 2,936,507 / 0 / 0 |
BIOCRYST PHARMACEUTICALS INCCOM | 09058V103 | $30.00B | 17.51% | 3,846,154shares | DFND | 3,846,154 / 0 / 0 |
Form type
13F-HR
Filing date
Apr 1, 2026
Holdings as of
December 31, 2025
Accession
0002081668-26-000003
CIK
0002081668
Other managers
2
Total Portfolio Value
$171.31B
Number of Positions
4
4 reported by filer
Top 10 Concentration
100.0%
Top 20 Concentration
100.0%
Unique Issuers
4
By CUSIP
Avg. Position Size
$42.83B
Across 4 holdings